Genomic characterization of spleens in patients with myelofibrosis

Lignende værker

• JAK2 inhibitors do not affect stem cells present in the spleens of patients with myelofibrosis
  af: Wang, Xiaoli, et al.
  Udgivet: (2014)
• Spleens of myelofibrosis patients contain malignant hematopoietic stem cells
  af: Wang, Xiaoli, et al.
  Udgivet: (2012)
• Sequential treatment of CD34(+) cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells
  af: Wang, Xiaoli, et al.
  Udgivet: (2010)
• Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms
  af: Tripodi, Joseph, et al.
  Udgivet: (2010)
• Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53
  af: Marcellino, Bridget K., et al.
  Udgivet: (2018)